These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8302392)

  • 1. Pathophysiology and therapy of heart failure, new insights and developments. Part II. Cardiac and peripheral alterations during progressive heart failure.
    Remme WJ
    Neth J Med; 1993 Oct; 43(3-4):125-46. PubMed ID: 8302392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congestive heart failure--pathophysiology and medical treatment.
    Remme WJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S36-52. PubMed ID: 2422492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathophysiologic and diagnostic aspects of heart failure].
    Rudolph W
    Herz; 1990 Jun; 15(3):147-57. PubMed ID: 2198215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology and therapy of heart failure, new insights and developments. Part I.
    Remme WJ
    Neth J Med; 1992 Oct; 41(3-4):171-82. PubMed ID: 1470289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New aspects of the pathophysiology of heart failure].
    Pieske B
    Wien Med Wochenschr; 1998; 148(5):108-20. PubMed ID: 9654696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathophysiology of cardiorenal regulatory mechanisms in heart failure].
    Holtz J; Finckh M
    Z Kardiol; 1991; 80 Suppl 2():1-10. PubMed ID: 2024537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The physiopathological aspects and new therapeutic approaches in cardiac-circulatory failure].
    Peruzzi G; Di Nardo P; Raimondi G; Legramante JM; Iellamo F; Massaro M; Bellegrandi F; Minieri M; Pafi M; Castrucci F
    Clin Ter; 1992 Nov; 141(11):339-72. PubMed ID: 1493659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognized molecular mechanisms of heart failure: approaches to treatment.
    Ceconi C; Cargnoni A; Curello S; Ferrari R
    Rev Port Cardiol; 1998 Oct; 17 Suppl 2():II79-91. PubMed ID: 9835784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baroreceptor function in congestive heart failure: effect on neurohumoral activation and regional vascular resistance.
    Hirsch AT; Dzau VJ; Creager MA
    Circulation; 1987 May; 75(5 Pt 2):IV36-48. PubMed ID: 2882866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure: an update on pathophysiology.
    Drexler H
    Arch Mal Coeur Vaiss; 1994 Jun; 87 Spec No 2():13-6. PubMed ID: 7864717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurohumoral mechanisms in cardiocirculatory decompensation].
    Grassi G; Mancia G
    Ann Ital Med Int; 1994 Oct; 9 Suppl():61S-67S. PubMed ID: 7857760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal hemodynamics in heart failure: implications for treatment.
    Rea ME; Dunlap ME
    Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):87-92. PubMed ID: 18090676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological bases of the treatment of cardiac insufficiency].
    Hannedouche T; Saoudi N
    Pathol Biol (Paris); 1987 Apr; 35(4):391-7. PubMed ID: 3035468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired baroreceptor control of renal sympathetic activity in human chronic heart failure.
    Al-Hesayen A; Parker JD
    Circulation; 2004 Jun; 109(23):2862-5. PubMed ID: 15173026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure and Starling's Law of the heart.
    ter Keurs HE
    Can J Cardiol; 1996 Oct; 12(10):1047-57. PubMed ID: 9191498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The time course of haemodynamic, autonomic and skeletal muscle metabolic abnormalities following first extensive myocardial infarction in man.
    Adamopoulos S; Kemp GJ; Thompson CH; Arnolda L; Brunotte F; Stratton JR; Radda GK; Rajagopalan B; Kremastinos DT; Coats AJ
    J Mol Cell Cardiol; 1999 Oct; 31(10):1913-26. PubMed ID: 10525428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal adaptation to the failing heart. Understanding the cascade of responses.
    Riley DJ; Weir M; Bakris GL
    Postgrad Med; 1994 Jun; 95(8):141-6, 149-50. PubMed ID: 8202419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synopsis of endocrine and hemodynamic changes in heart failure].
    Wedler B
    Z Kardiol; 1991; 80 Suppl 8():53-6. PubMed ID: 1796635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone, acromegaly, and heart failure: an intricate triangulation.
    Saccà L; Napoli R; Cittadini A
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.